Literature DB >> 4791976

Cell-mediated immunity to hepatitis-associated antigen (HAA) demonstrated by leucocyte migration test during and after acute B hepatitis.

P C Frei, P Erard, R Zinkernagel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4791976

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


× No keyword cloud information.
  7 in total

1.  Immune response to purified non-A, non-B hepatitis-related antigen demonstrated by leukocyte migration inhibition in patients recovering from the infection.

Authors:  A Nicole; O Spertini; D Lavanchy; P C Frei
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

2.  Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen.

Authors:  P Erard
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

Review 3.  The immunopathology of acute type B hepatitis.

Authors:  L Bianchi
Journal:  Springer Semin Immunopathol       Date:  1981-04

4.  [Investigations concerning the fixation of hepatitis B-antigen (HBAg) on peripheral lymphocytes and isolated hepatocytes in patients with inflammatory liver diseases. (author's transl)].

Authors:  W Arnold; K H Meyer zum Büschenfelde; U Hopf; C Kordbarlag
Journal:  Klin Wochenschr       Date:  1975-03-01

5.  Immune response to hepatitis B surface antigen.

Authors:  A B Ibrahim; G N Vyas; H A Perkins
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

6.  Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen.

Authors:  J J Vallotton; P C Frei
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis.

Authors:  W M Lee; W D Reed; C G Osman; J Vahrman; A J Zuckerman; A L Eddleston; R Williams
Journal:  Gut       Date:  1977-03       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.